HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients. Breadcrumbs UL Home Research Publications Year of Publication 2017 Journal Cancer Immunology Immunotherapy DOI 10.1007/s00262-017-1983-1
